Skip to Main Content

There are plenty of reasons to envy Grail, the Google-backed company seeking to revolutionize how cancer is diagnosed. The company has raised more than $1 billion, pulled off a series of high-profile hires, and made a splash in the New England Journal of Medicine.

But organizational stability may not be one of them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!